IRRCS Instituto Clinico Humanitas

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Head and neck cancer

Closed trials

• Completed

  Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304)

  NCT03358472· Phase 3· Incyte Corporation· Source